IGF2 and Alzheimer disease: Extensive abnormalities in insulin and insulin-like growth factor type I and II (IGF-I and IGF-II) signaling pathways in the brains of patients with AD suggest that AD may partially share characteristics with a neuroendocrine disease similar to DM (Xu et al., 2015).